findmyKOL
Clinical trialNCT04078152CompletedPhase 4Interventional

Durvalumab Long-Term Safety and Efficacy Study

SponsorAstraZenecaEnrollment163Solid Tumor
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

116 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina
  • Research Site

    Rosario, Argentina

Australia
  • Research Site

    Box Hill, Australia

  • Research Site

    Melbourne, Australia

Belgium
  • Research Site

    Brussels, Belgium

  • Research Site

    Kortrijk, Belgium

  • Research Site

    Leuven, Belgium

Brazil
  • Research Site

    Florianópolis, Brazil

  • Research Site

    Ijuí, Brazil

  • Research Site

    Porto Alegre, Brazil

  • Research Site

    São José do Rio Preto, Brazil

Bulgaria
  • Research Site

    Sofia, Bulgaria

Canada
  • Research Site

    Calgary, Alberta, Canada

  • Research Site

    Toronto, CA, Canada

  • Research Site

    Greater Sudbury, Ontario, Canada

  • Research Site

    Newmarket, Ontario, Canada

Chile
  • Research Site

    Santiago, Chile

Czechia
  • Research Site

    Olomouc, Czechia

France
  • Research Site

    Brest, France

  • Research Site

    Lille, France

  • Research Site

    Lyon, France

Germany
  • Research Site

    Dresden, Germany

  • Research Site

    Hanover, Germany

Greece
  • Research Site

    Holargos, Athens, Greece

Hungary
  • Research Site

    Budapest, Hungary

  • Research Site

    Miskolc, Hungary

India
  • Research Site

    Chennai, India

Israel
  • Research Site

    Haifa, Israel

Japan
  • Research Site

    Bunkyō City, Japan

  • Research Site

    Fukushima, Japan

  • Research Site

    Isehara-shi, Japan

  • Research Site

    Izumi-shi, Japan

  • Research Site

    Kishiwada-shi, Japan

  • Research Site

    Kōtoku, Japan

  • Research Site

    Nagaoka-shi, Japan

  • Research Site

    Nagoya, Japan

  • Research Site

    Natori-shi, Japan

  • Research Site

    Okayama, Japan

  • Research Site

    Osaka, Japan

  • Research Site

    Saga, Japan

  • Research Site

    Suita-shi, Japan

76 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
5 Sept 2019
Primary completion
31 Oct 2022
Completion
31 Oct 2024
Last update posted
20 Dec 2024
Registered enrollment
163
Registry id
NCT04078152

Cross-registrations

EU-CTR / CTIS (EudraCT)2019-001402-20

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.